Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
20th Annual Rehabilitation In Multiple Sclerosis (RIMS) Conference
Episode 46 with Dr. Hans Lassmann on biomarkers in NMO and MS
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Episode 44 with Dr. Monika Bradl on an animal model for neuromyelitis optica (NMO)
American Society for Neurochemistry 47th Annual Meeting
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
MS Research Roundup: July 17, 2014
Direct immunomodulatory influence of IFN-β on human astrocytoma cells.
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
ACTRIMS-ECTRIMS 2014 -- Day 2, afternoon
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Gender-specific expression of beta1 integrin of VLA-4 in myelin basic protein-primed T cells: implications for gender bias in multiple sclerosis.
An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation.
FP187 – Oral Immunomodulatory Dimethyl Fumarate (DMF)
No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis.
Zist Daru, ZIFERON
Episode 55 with Dr. Michael Levy on the status of regenerative stem cell therapies for multiple sclerosis
XVI European Charcot Foundation lecture: nutrition and environment, can MS be prevented?
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls.

Pages